Mouse Anti-OTUD6B Recombinant Antibody (11F7) (CBMAB-0788-CN)

Li, L., Zhu, R., Zhou, H., Cui, C. P., Yu, X., Liu, Y., ... & Liu, Z. (2023). All‐Trans Retinoic Acid Promotes a Tumor Suppressive OTUD6B‐β‐TrCP‐SNAIL Axis in Esophageal Squamous Cell Carcinoma and Enhances Immunotherapy. Advanced Science, 10(16), 2207458.

Wang, Z., Zhang, L., Li, L., & Zhou, M. (2022). Loss of OTUD6B stimulates angiogenesis and promotes diabetic atherosclerosis. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 3027-3038.

Cingöz, S., Soydemir, D., Öner, T. Ö., Karaca, E., Özden, B., Kurul, S. H., ... & University of Washington Center for Mendelian Genomics. (2022). Novel biallelic variants affecting the OTU domain of the gene OTUD6B associate with severe intellectual disability syndrome and molecular dynamics simulations. European journal of medical genetics, 65(6), 104497.

Zhao, G., Song, D., Wu, J., Yang, S., & Zhang, B. (2022). Identification of OTUD6B as a new biomarker for prognosis and immunotherapy by pan-cancer analysis. Frontiers in immunology, 13, 955091.

Guo, K., Wei, Y., Wang, Z., Zhang, X., Zhang, X., Liu, X., ... & Cui, C. P. (2022). Deubiquitylase OTUD6B stabilizes the mutated pVHL and suppresses cell migration in clear cell renal cell carcinoma. Cell Death & Disease, 13(2), 97.

Abdel-Salam, G. M., Abdel-Hamid, M. S., Sayed, I. S., Zechner, U., & Bolz, H. J. (2022). OTUD6B-associated intellectual disability: Novel variants and genetic exclusion of retinal degeneration as part of a refined phenotype. Journal of Human Genetics, 67(1), 55-64.

Zhou, Z., Cai, X., Zhu, J., Li, Z., Yu, G., Liu, X., ... & Xiao, W. (2021). Zebrafish otud6b negatively regulates antiviral responses by suppressing K63-linked ubiquitination of irf3 and irf7. The Journal of Immunology, 207(1), 244-256.

Liu, X., Zhang, X., Peng, Z., Li, C., Wang, Z., Wang, C., ... & Zhang, L. (2020). Deubiquitylase OTUD6B governs pVHL stability in an enzyme‐independent manner and suppresses hepatocellular carcinoma metastasis. Advanced Science, 7(8), 1902040.

Kong, S., Xue, H., Li, Y., Li, P., Ma, F., Liu, M., & Li, W. (2020). The long noncoding RNA OTUD6B-AS1 enhances cell proliferation and the invasion of hepatocellular carcinoma cells through modulating GSKIP/Wnt/β-catenin signalling via the sequestration of miR-664b-3p. Experimental Cell Research, 395(1), 112180.

Wang, G., Zhang, Z. J., Jian, W. G., Liu, P. H., Xue, W., Wang, T. D., ... & Zhang, C. (2019). Novel long noncoding RNA OTUD6B-AS1 indicates poor prognosis and inhibits clear cell renal cell carcinoma proliferation via the Wnt/β-catenin signaling pathway. Molecular cancer, 18, 1-15.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols